Kymera Therapeutics (KYMR)CFO sold ~$3.96M
Bruce N. Jacobs, CFO at Kymera Therapeutics, sold ~$3.96M of Kymera Therapeutics shares.
- ~$3.96M
- Approx. value · 79K sh @ $50.00
- 227K
- Holds after · shares reported
- Traded
- Sep 17, 2025
- Filed
- Sep 17, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 16, 2025InsiderCEO sold ~$1.47M of KYMR shares in the open market
- Sep 17, 2025 · this disclosureInsider · Their largest sale since 2021CFO sold ~$3.96M of KYMR shares in the open market
What came next
- Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
- Dec 8, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- Jan 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Kymera Therapeutics
For Kymera Therapeutics, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KYMR page.
Other recent filings by Bruce N. Jacobs, Chief Financial Officer
- SEC Form 4 at Kymera Therapeutics (KYMR)Mar 3, 2025
- SEC Form 4 at Kymera Therapeutics (KYMR)Mar 3, 2025
The full history of Bruce N. Jacobs, Chief Financial Officer is on the profile page.
How this filing works
Other disclosures at Kymera Therapeutics
- SEC Form 4Oct 1, 2026
- SEC Form 4Oct 1, 2026
- SEC Form 4Oct 1, 2026
- SEC Form 4Oct 1, 2026
- SEC Form 4Oct 1, 2026
- SEC Form 4Oct 1, 2026
Everything OQRO holds on this company is on its KYMR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data